- Home
- GH vs GLOB Comparison
GH vs GLOB Comparison
Compare GH & GLOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GH | GLOB |
|---|---|---|
| Founded | 2011 | 2003 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Medical Specialities | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.7B |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GH | GLOB |
|---|---|---|
| Price | $103.60 | $64.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 14 |
| Target Price | $79.19 | ★ $95.71 |
| AVG Volume (30 Days) | ★ 2.9M | 1.4M |
| Earning Date | 10-29-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.19 |
| Revenue | $902,569,000.00 | ★ $2,484,891,000.00 |
| Revenue This Year | $34.72 | $3.49 |
| Revenue Next Year | $26.46 | $2.36 |
| P/E Ratio | ★ N/A | $29.45 |
| Revenue Growth | ★ 30.38 | 5.56 |
| 52 Week Low | $29.91 | $54.36 |
| 52 Week High | $112.43 | $234.78 |
Technical Indicators
Market Signals| Indicator | GH | GLOB |
|---|---|---|
| Relative Strength Index (RSI) | 66.40 | 58.48 |
| Support Level | $98.23 | $62.47 |
| Resistance Level | $112.43 | $63.79 |
| Average True Range (ATR) | 5.44 | 2.75 |
| MACD | -0.54 | 0.35 |
| Stochastic Oscillator | 64.46 | 93.02 |
Price Performance
Historical ComparisonAbout GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About GLOB Globant S.A.
Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.